Picture of International Biotechnology Trust logo

IBT International Biotechnology Trust News Story

0.000.00%
gb flag iconLast trade - 00:00
FinancialsBalancedSmall Cap

REG - Intnl. Biotechnology - Result of AGM

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20251212:nRSL4629La&default-theme=true

RNS Number : 4629L  Intl. Biotechnology Trust PLC  12 December 2025

Annual General Meeting

International Biotechnology Trust plc (the "Company") announces that a poll
was held on each of the resolutions proposed at the Annual General Meeting
("AGM") on 12 December 2025. The results of the poll are:

      Resolution                                                                    Votes For   %      Votes Against  %      Votes Withheld  Total Votes Cast (excl. Votes Withheld)  % of Issued Share Capital
 1    To receive the Annual Report and Financial Statements                         9,807,779   88.62  1,259,469      11.38  13,267          11,067,248                               34.69
 2    To approve the Company's dividend policy                                      11,051,409  99.96  4,027          0.04   25,079          11,055,436                               34.65
 3    To approve the Directors' Remuneration Report                                 10,969,750  99.41  65,531         0.59   45,234          11,035,281                               34.59
 4    To elect Alexa Henderson                                                      11,014,335  99.75  27,060         0.25   39,120          11,041,395                               34.61
 5    To re-elect Gillian                                                           10,989,914  99.53  52,254         0.47   38,347          11,042,168                               34.61

       Elcock
 6    To re-elect Kate Cornish-Bowden                                               11,011,634  99.72  30,534         0.28   38,347          11,042,168                               34.61
 7    To re-elect Patrick                                                           11,040,180  99.88  13,800         0.12   26,535          11,053,980                               34.65

      Magee
 8    To re-elect Patrick Maxwell                                                   11,041,440  99.90  10,947         0.10   28,128          11,052,387                               34.64
 9    To appoint Johnston Carmichael LLP as Auditors                                11,031,249  99.80  21,652         0.20   27,614          11,052,901                               34.65
 10   To authorise the Directors' determination of the remuneration of Johnston     11,034,924  99.86  15,310         0.14   30,281          11,050,234                               34.64
      Carmichael LLP
 11   To approve the continuation of the Company                                    11,064,221  99.95  5,864          0.05   10,430          11,070,085                               34.70
 12   To renew the Directors' authority to allot shares                             11,039,634  99.80  22,029         0.20   18,852          11,061,663                               34.67
 13*  To approve the disapplication of pre-emption rights                           10,957,526  99.31  76,546         0.69   46,443          11,034,072                               34.59

 14*  To renew the authority to make market purchases of the Company's own shares   10,707,128  96.85  348,476        3.15   24,841          11,055,604                               34.65
 15*  To approve that a general meeting, other than an annual general meeting, may  11,029,481  99.70  32,818         0.30   18,216          11,062,299                               34.67
      be called on not less than 14 clear days' notice

 

*Resolutions 13 to 15 were passed as special resolutions. Copies of
resolutions 11 to 15 will be filed at Companies House.

 

Shareholders are entitled to one vote per share. Votes withheld are not a vote
in law and are therefore not counted in the calculation of the percentages of
the votes cast for and against a resolution. Where shareholders appointed the
Chair as their proxy with discretion as to voting, their votes were cast in
favour of the resolutions and their shares have been included in the "votes
for" column.

 

The total issued share capital consists of 41,383,817 ordinary shares
of £0.25 each, which includes 9,480,983 ordinary shares held in treasury.
Treasury shares do not carry voting rights, therefore the total number voting
rights in the Company is 31,902,834.

 

In accordance with UKLR 6.4.2, a copy of the resolutions passed, other than
the resolutions concerning ordinary business, at today's AGM will be submitted
to the National Storage Mechanism and will be available for inspection
at https://data.fca.org.uk/#/nsm/nationalstoragemechanism
(https://data.fca.org.uk/#/nsm/nationalstoragemechanism) .

 

The proxy votes lodged with the Company's Registrar will shortly be available
via the Company's web pages at International Biotechnology Trust plc - IBT
(https://www.schroders.com/en-gb/uk/individual/funds-and-strategies/investment-trusts/international-biotechnology-trust/)
.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  RAGFFWFWEEISELE



            Copyright 2019 Regulatory News Service, all rights reserved

Recent news on International Biotechnology Trust

See all news